Atlas Trials

The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block

Clinical trial NCT04196270 · UNKNOWN

Trial details

NCT number
NCT04196270
Sponsor
Zealand University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Percutaneous Nephrolithotomy
Start date
2020-01-05
Primary completion
2020-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.